ATE533775T1 - Verfahren zur herstellung von 17-vinyl-triflaten als intermediate - Google Patents

Verfahren zur herstellung von 17-vinyl-triflaten als intermediate

Info

Publication number
ATE533775T1
ATE533775T1 AT05781067T AT05781067T ATE533775T1 AT E533775 T1 ATE533775 T1 AT E533775T1 AT 05781067 T AT05781067 T AT 05781067T AT 05781067 T AT05781067 T AT 05781067T AT E533775 T1 ATE533775 T1 AT E533775T1
Authority
AT
Austria
Prior art keywords
producing
formula
vinyl triflates
triflates
vinyl
Prior art date
Application number
AT05781067T
Other languages
English (en)
Inventor
Paul Stanley Bury
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35311370&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533775(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0418901A external-priority patent/GB0418901D0/en
Priority claimed from GBGB0418900.7A external-priority patent/GB0418900D0/en
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of ATE533775T1 publication Critical patent/ATE533775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05781067T 2004-08-24 2005-08-23 Verfahren zur herstellung von 17-vinyl-triflaten als intermediate ATE533775T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60355804P 2004-08-24 2004-08-24
GB0418901A GB0418901D0 (en) 2004-08-24 2004-08-24 Synthetic method
GBGB0418900.7A GB0418900D0 (en) 2004-08-24 2004-08-24 Novel salt forms
PCT/GB2005/003283 WO2006021777A1 (en) 2004-08-24 2005-08-23 Process fot the preparation of 17-0-vinyl- triflates as intermediates

Publications (1)

Publication Number Publication Date
ATE533775T1 true ATE533775T1 (de) 2011-12-15

Family

ID=35311370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05781067T ATE533775T1 (de) 2004-08-24 2005-08-23 Verfahren zur herstellung von 17-vinyl-triflaten als intermediate

Country Status (11)

Country Link
US (2) US8236946B2 (de)
EP (2) EP2428519B1 (de)
JP (1) JP5199667B2 (de)
AT (1) ATE533775T1 (de)
CY (1) CY1112283T1 (de)
DK (2) DK2428519T3 (de)
ES (2) ES2377074T3 (de)
PL (2) PL2428519T3 (de)
PT (2) PT2428519E (de)
SI (2) SI2428519T1 (de)
WO (1) WO2006021777A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102030798B (zh) * 2010-12-17 2012-10-17 深圳万乐药业有限公司 一种醋酸阿比特龙的纯化方法
CN104066744B (zh) 2011-10-10 2017-03-22 扎克系统公司 用于制备17‑取代的甾体的方法
EP2607371A1 (de) 2011-12-23 2013-06-26 Crystal Pharma, S.A.U. Verfahren zur Herstellung von Abirateron und verwandten Verbindungen
CN103172690B (zh) * 2011-12-23 2016-08-24 重庆医药工业研究院有限责任公司 醋酸阿比特龙及其中间体的制备方法
CN103193849B (zh) * 2012-01-04 2016-05-04 连云港润众制药有限公司 一种高纯度醋酸阿比特龙的制备方法
CN103254265B (zh) 2012-02-21 2016-07-13 上海希迈医药科技有限公司 醋酸阿比特龙三氟乙酸盐及其制备方法和应用
US9511152B2 (en) * 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
WO2014009434A1 (en) 2012-07-11 2014-01-16 Sandoz Ag Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate
WO2014009436A1 (en) 2012-07-11 2014-01-16 Sandoz Ag Nanosuspension of abiraterone acetate
WO2014009437A1 (en) 2012-07-11 2014-01-16 Sandoz Ag Oxidation stability of abiraterone acetate
WO2014016830A1 (en) * 2012-07-25 2014-01-30 Mapi Pharma Ltd. Process and intermediates for the preparation of abiraterone acetate
CN102816200B (zh) * 2012-09-05 2015-04-15 中山大学 一种醋酸阿比特龙的制备方法
ITMI20121788A1 (it) 2012-10-22 2014-04-23 Olon Spa Procedimento per la purificazione di abiraterone acetato
EP2917225A1 (de) 2012-11-09 2015-09-16 Synthon BV Verfahren zur herstellung von abirateron-3-acetat
WO2014071983A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making the 17-triflate intermediate of abiraterone-3-acetate
WO2014075978A1 (en) 2012-11-16 2014-05-22 Synthon B.V. Process for the production of abiraterone-3-acetate involving an enol trliflation reaction in the presence of an alkoxy-pyridine compound
US20150343099A1 (en) 2012-12-19 2015-12-03 Bayer Pharma Aktiengesellschaft Combination comprising radium-223 for the treatment of cancer
EP2938625B1 (de) * 2012-12-31 2018-02-21 Hetero Research Foundation Verfahren zur herstellung von abirateronacetat
PL2792682T3 (pl) 2013-04-19 2017-04-28 Zach System Sposób wytwarzania stałej postaci octanu abirateronu
CN103242410B (zh) * 2013-05-09 2015-08-26 苏州明锐医药科技有限公司 醋酸阿比特龙的制备方法
US20160176915A1 (en) * 2013-06-24 2016-06-23 Sun Pharmaceutical Industries Limited Process for preparation of abiraterone acetate
CA2914305A1 (en) * 2013-06-28 2014-12-31 Scinopharm Taiwan, Ltd. Process for the preparation of abiraterone and intermediates thereof
ITMI20131861A1 (it) * 2013-11-08 2015-05-09 Ind Chimica Srl Processo per la preparazione di abiraterone e abiraterone acetato
CA2919484C (en) 2013-07-29 2021-05-11 Industriale Chimica S.R.L. Process for the preparation of abiraterone or abiraterone acetate
US9650410B2 (en) 2013-07-29 2017-05-16 Industriale Chimica S.R.L. Process for the preparation of abiraterone and abiraterone acetate
CN104418930B (zh) * 2013-08-23 2018-01-12 四川海思科制药有限公司 一种高纯度醋酸乌利司他
WO2015114518A2 (en) 2014-01-28 2015-08-06 Olon S.P.A. Procedure for the preparation of abiraterone acetate and intermediates thereof
CN103965282B (zh) 2014-04-21 2016-01-20 武汉百科药物开发有限公司 一种醋酸阿比特龙的制备方法
US9315541B2 (en) * 2014-05-20 2016-04-19 Olon S.P.A. Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives
EP3160450A1 (de) 2014-06-30 2017-05-03 Galenicum Health S.L. Stabile pharmazeutische zusammensetzungen in form von tabletten mit unmittelbarer freisetzung
CZ2014475A3 (cs) 2014-07-09 2016-01-20 Zentiva, K.S. Způsob přípravy Abirateron acetátu o vysoké čistotě aplikovatelný v průmyslovém měřítku
CN105622703B (zh) * 2014-11-05 2019-09-27 兰州大学 一种制备醋酸阿比特龙的方法
CN104447934B (zh) * 2014-12-08 2017-03-15 深圳科兴生物工程有限公司 一种醋酸阿比特龙的纯化方法
HU231297B1 (hu) 2018-07-31 2022-09-28 Richter Gedeon Nyrt Stabil gyógyszerkészítmények és eljárás az előállításukra
CN112812147A (zh) * 2019-11-15 2021-05-18 江苏佳尔科药业集团股份有限公司 一种醋酸阿比特龙的合成方法及其中间体
EP3944860A1 (de) 2020-07-30 2022-02-02 Galenicum Health S.L.U. Abirateron zur verwendung in einem verfahren zur behandlung von krebs
KR102583796B1 (ko) 2021-07-28 2023-09-27 오스템임플란트 주식회사 골 이식량 결정 방법 및 장치, 컴퓨터 판독 가능한 기록 매체 및 컴퓨터 프로그램
US20250296952A1 (en) 2022-05-06 2025-09-25 Aurisco Pharmaceutical Co., Ltd. Method for preparing abiraterone acetate and intermediate thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4207851A1 (de) * 1992-03-12 1993-09-16 Bayer Ag Mittel und verfahren zur ausruestung von textilien
CA2132449C (en) 1992-03-31 2002-09-10 Susan E. Barrie 17 - substituted steroids useful in cancer treatment
US5338875A (en) 1992-11-19 1994-08-16 Merck & Co., Inc. Boron containing intermediates useful in the preparation of carbapenems
AU676088B2 (en) 1993-09-30 1997-02-27 British Technology Group Limited Synthesis of 17-(3-pyridyl) steroids
US5466770A (en) * 1994-05-26 1995-11-14 Minnesota Mining And Manufacturing Company Fluorine-efficient oil- and water-repellent compositions
JP3982012B2 (ja) * 1997-01-30 2007-09-26 ダイキン工業株式会社 新規組成物および処理剤
US5994334A (en) 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
JP3399286B2 (ja) * 1997-04-11 2003-04-21 ダイキン工業株式会社 防汚加工剤組成物
JPH10316719A (ja) * 1997-05-20 1998-12-02 Daikin Ind Ltd 新規重合体およびそれを含む防汚加工剤組成物
US6059868A (en) * 1998-10-29 2000-05-09 Hewlett-Packard Company Ink-jet inks with improved performance
WO2000037583A1 (fr) * 1998-12-22 2000-06-29 Daikin Industries, Ltd. Dispersion aqueuse hydrophobe et oleophobe
JP2000212549A (ja) * 1999-01-25 2000-08-02 Asahi Glass Co Ltd 撥水撥油剤組成物およびその製造方法
US6274060B1 (en) * 1999-02-04 2001-08-14 Daikin Industries, Ltd. Water- and oil-repellent
US6894106B2 (en) * 2000-09-21 2005-05-17 Daikin Industries, Ltd. Aqueous dispersion of water- and oil-repellent and process for the production thereof
WO2002064696A1 (en) * 2001-01-30 2002-08-22 Daikin Industries, Ltd. Water- and oil-repellent composition, process for producing the same and use thereof
WO2002072727A1 (en) * 2001-03-09 2002-09-19 Daikin Industries, Ltd. Water-and-oil repellant composition with improved suitability for cold cure
KR100889714B1 (ko) * 2001-04-13 2009-03-23 아사히 가라스 가부시키가이샤 발수발유제 조성물
KR100605415B1 (ko) * 2002-01-21 2006-08-02 다이킨 고교 가부시키가이샤 발수 발유제 수성 분산액
JPWO2004000795A1 (ja) 2002-06-20 2005-10-20 協和醗酵工業株式会社 ビニルパーフルオロアルカンスルホン酸エステル誘導体の製造法
CN100351339C (zh) * 2002-10-15 2007-11-28 旭硝子株式会社 防水防油剂组合物
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms

Also Published As

Publication number Publication date
CY1112283T1 (el) 2015-12-09
PL1781683T3 (pl) 2012-04-30
WO2006021777A1 (en) 2006-03-02
US8389714B2 (en) 2013-03-05
JP5199667B2 (ja) 2013-05-15
JP2008510781A (ja) 2008-04-10
EP2428519A2 (de) 2012-03-14
SI2428519T1 (sl) 2015-07-31
US20070282109A1 (en) 2007-12-06
DK1781683T3 (da) 2012-02-06
EP2428519A3 (de) 2014-01-15
HK1167658A1 (en) 2012-12-07
ES2377074T3 (es) 2012-03-22
PT1781683E (pt) 2012-02-13
PL2428519T3 (pl) 2015-09-30
US20110288288A1 (en) 2011-11-24
SI1781683T1 (sl) 2012-06-29
ES2534587T3 (es) 2015-04-24
US8236946B2 (en) 2012-08-07
PT2428519E (pt) 2015-04-29
EP1781683A1 (de) 2007-05-09
EP1781683B1 (de) 2011-11-16
EP2428519B1 (de) 2015-01-21
DK2428519T3 (en) 2015-04-13

Similar Documents

Publication Publication Date Title
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
ATE371657T1 (de) Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin
DE60311599D1 (de) Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE370736T1 (de) Verfahren zur herstellung eines piperazinderivates
ATE554083T1 (de) Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung
ATE255103T1 (de) Verfahren zur herstellung von pyridinmethanol- verbindungen
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
DE602005026827D1 (de) Verfahren zur herstellung von isoindolderivaten
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE310735T1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
ATE501115T1 (de) Verfahren zur herstellung von entacapon
ATE366719T1 (de) Verfahren zur herstellung von 2,6- dichlorphenolverbindungen